Menu
Back to Archived Journals » Core Evidence » Volume 11
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 11, 2016
Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy
Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R
Core Evidence 2016, 11:49-61
Published Date: 14 December 2016
Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy
Serratrice C, Carballo S, Serratrice J, Stirnemann J
Core Evidence 2016, 11:37-47
Published Date: 14 October 2016
Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy
Buti S, Leonetti A, Dallatomasina A, Bersanelli M
Core Evidence 2016, 11:23-36
Published Date: 1 September 2016
Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy
Margaritopoulos GA, Vasarmidi E, Antoniou KM
Core Evidence 2016, 11:11-22
Published Date: 1 July 2016
Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapy
Angeloni E
Core Evidence 2016, 11:1-10
Published Date: 5 April 2016